C07J 1/0029
Ethers
Official title: {Ethers}
C07J1/0029 (Ethers) appears on 20 US grants and 42 published applications in this corpus.
Search patents in C07J- Granted patents
- 20
- Published applications
- 42
- Assignees
- 15
- Inventors
- 62
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 2 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 1 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 2 |
| 2015 | 0 | 3 |
| 2016 | 0 | 1 |
| 2017 | 2 | 4 |
| 2018 | 0 | 3 |
| 2019 | 1 | 3 |
| 2020 | 1 | 1 |
| 2021 | 0 | 2 |
| 2022 | 3 | 2 |
| 2023 | 1 | 4 |
| 2024 | 2 | 2 |
| 2025 | 0 | 7 |
| 2026 | 1 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- C17, C20, and C21 substituted neuroactive steroids and their methods of use16 Jun 2026US 12,655,175 B2Sage Therapeutics, Inc.
- Neuroactive steroids, compositions, and uses thereof29 Oct 2024US 12,129,275 B2Sage Therapeutics, Inc.
- C7, C12, and C16 substituted neuroactive steroids and their methods of use28 May 2024US 11,993,628 B2Sage Therapeutics, Inc.
- Lymph directing prodrugs29 Aug 2023US 11,738,087 B2Monash University
- C17, C20, and C21 substituted neuroactive steroids and their methods of use26 Jul 2022US 11,396,525 B2Sage Therapeutics, Inc.
- Lymph directing prodrugs24 Sep 2026US 2026/0284004 A1Monash University
- Novel method for preparing testosterone derivatives by solid-phase synthesis25 Jun 2026US 2026/0174913 A1King Faisal Specialist Hospital & Research Centre
- Lymph directing prodrugs4 Jun 2026US 2026/0151489 A1Monash University
- Lymph directing prodrugs16 Apr 2026US 2026/0102373 A1Monash University
- Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same5 Feb 2026US 2026/0034146 A1Sage Therapeutics, Inc.
Most cited
By later US patents
- Neuroactive steroids of the androstane and pregnane series114US 5,925,630 ACoCensys, Inc. · 1999
- Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same48US 9,630,986 B2Sage Therapeutics, Inc. · 2017
- 4-substituted 17.beta.-(cyclopropyloxy)androst-5-en-3.beta.-ol and related compounds useful as C17-20 lyase inhibitors25US 4,966,897 AMerrell Dow Pharmaceuticals Inc. · 1990
- 20/22/23/24-Oxa-7-oxocholesterols and esters thereof24US 4,125,544 AG. D. Searle & Co. · 1978
- Neuroactive steroids of the androstane and pregnane series17US 6,780,853 B1Euro-Celtique S. A. · 2004